49 / 464
49
Programme and Exhibition Guide |
PROGRAMME
08:55-09:55
Session 1: What are the methodological and practical challenges
associated with the collection and use of PROMs?
08:55-09:25
Selection of measures; Time points; Electronic vs paper
B. Holzner (AU)
09:25-09:35
Translation into different languages
S. Davidson (UK)
09:35-09:55
Patient understanding and non-compliance
T. Holch (UK)
09:55-10:25
Coffee break
10:25-12:05
Session 2: Implementation of PROM in research and clinical practice in
different cancer sites
10:25-10:50
Prostate and lung cancer
A. Henry (UK)
10:50-11:15
Breast and head and neck cancer
P. Bidstrup (DK)
11:15-11:40
Gynaecological cancer
S. Davidson (UK)
11:40-12:05
REQUITE study (radiogenomics)
C. West (UK)
12:05-13:05
Lunch
13:05-14:05
Session 3: Using PROMs and dose-volume parameters to understand
treatment complications
13:05-13:35
The advantages of using PROMs as the basis for
complication probability modelling
J. Deasy (USA)
13:35-14:05
Role of PROMs in the model-based selection of patients for
proton therapy
H. Langendijk (NL)
14:05-15:35
Session 4: ePROMs
14:05-14:35
eRAPID: feasibility of completion during and six months post
treatment
T. Holch (UK)
14:35-15:05
OPTIMAL: longitudinal follow up using ePROMS
A. Gilbert (UK)